CNPAX
Price
$72.41
Change
+$0.05 (+0.07%)
Updated
Jun 24 closing price
Net Assets
171.51B
SGARX
Price
$20.43
Change
-$0.00 (-0.00%)
Updated
Jun 24 closing price
Net Assets
144.44M
Interact to see
Advertisement

CNPAX vs SGARX

CNPAX vs SGARX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. SGARX commentary
Jun 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and SGARX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 172B vs. SGARX (144M). CNPAX pays higher dividends than SGARX: CNPAX (0.95) vs SGARX (0.00). CNPAX was incepted earlier than SGARX: CNPAX (24 years) vs SGARX (15 years). SGARX (1.03) is less costly to investors than CNPAX (0.74). SGARX is a more actively managed with annual turnover of: 37.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than SGARX: CNPAX (250) vs SGARX (2500000). CNPAX annual gain was more profitable for investors over the last year : 8.60 vs. SGARX (-19.50). CNPAX return over 5 years is better than : 13.35 vs. SGARX (-36.45).
CNPAXSGARXCNPAX / SGARX
Total Expense Ratio0.740.9082%
Annual Report Gross Expense Ratio0.741.0372%
Fund Existence24 years15 years-
Gain YTD4.488-8.303-54%
Front Load4%N/A-
Min. Initial Investment25025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets172B144M119,444%
Annual Yield % from dividends0.950.00-
Returns for 1 year8.60-19.50-44%
Returns for 3 years38.90-17.55-222%
Returns for 5 years13.35-36.45-37%
Returns for 10 years127.8039.16326%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HNCCX21.09N/A
N/A
Hartford International Growth C
MUERX37.89N/A
N/A
MFS Blended Research Core Equity R1
GIRVX9.12N/A
N/A
Goldman Sachs Intl Eq Div & Prem Inv
NRAAX62.89N/A
N/A
Neuberger Quality Equity A
RWIBX78.68-0.44
-0.56%
American Funds Capital World Gr&Inc R2